Wegovy Weight Loss Injection | Semaglutide | What You Need to Know

About Wegovy

Wegovy is a prescription medication containing Semaglutide, which is used for chronic weight management in adults who are obese or overweight. This branded drug is approved by the FDA in the U.S. and the MHRA in the UK. It mimics your natural hormone, GLP-1, which regulates appetite, helping reduce calorie intake and hunger. 

Unlike the non-prescription ways to reduce your weight, like diet supplements or over-the-counter products, Wegovy is a medically approved treatment that has already been successful in several studies, such as in STEP (Semaglutide Treatment Effect in People with Obesity) clinical trials. This once-weekly medication is administered subcutaneously and is a medically supervised method for long-term weight control. 

How Does Wegovy Work?

Wegovy mimics the action of a glucagon-like peptide-1 (GLP-1) hormone that is naturally produced in your body. It binds and activates the GLP-1 receptors, regulating food intake and lowering appetite. 

Wegovy increases the feelings of fullness, slows the gastric emptying process, and reduces appetite, leading to weight loss and reduced calorie consumption. Semaglutide (Wegovy), unlike the body's natural GLP-1, which breaks down rapidly in your body, has a prolonged half-life. It shows great efficacy with one subcutaneous weekly injection and maintains appetite control over time.

What Are the Requirements to Qualify for Wegovy?

You need to meet specific medical criteria to qualify for Wegovy, including having a BMI (body mass index) of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, or hyperlipidemia. It is a prescription-only medication and must be prescribed by a qualified doctor after a complete evaluation. 

However, it is not suitable for people who are pregnant or trying to become pregnant, or those with a history of pancreatitis or any other medical conditions. Before using Wegovy, consult your doctor to determine whether it is safe for you.

What Must You Know Before Starting Semaglutide for Weight Loss?

Prior to initiating Semaglutide therapy for weight loss, it is imperative to have an evaluation with a qualified healthcare provider to determine whether this treatment is safe for you. You must tell your doctor about your medical history and your family's medical history and current medications, as certain conditions like a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 may make Semaglutide inappropriate. 

Commit to ongoing lifestyle changes such as regular physical activity and a balanced diet to achieve optimal results and maintain them in the long run. Also, learn proper self-injection techniques as Wegovy is administered subcutaneously once a week. To maximize benefits and lessen the risk associated with Semaglutide, a clear understanding and adequate preparation is essential.

Wegovy Reviews and Success Rates

Healthcare professionals and people who have used Wegovy shared positive reviews, and these reviews are supported by emerging real-world data and clinical trials. In the STEP 1 clinical study, people who have used Wegovy with lifestyle interventions lost about 15% of their initial body weight within 68 weeks, more than those receiving a placebo. The results vary from person to person based on their physical activity, medical supervision, and adherence to a healthy diet. 

 Wegovy vs. Ozempic: Which One is the Best?

Both Ozempic and Wegovy contain Semaglutide as an active component, but they are approved for different conditions and are not interchangeable. Wegovy is specifically licensed for chronic weight management in obese adults or overweight people with related health conditions. On the other hand, Ozempic is indicated for managing type 2 diabetes. While they have the same active ingredient, Wegovy is prescribed at a higher maintenance dose, such as 2.4 mg once weekly, compared to Ozempic (1 mg once weekly), and thus has greater effectiveness for weight loss. Always use each medication under medical supervision, as improper use or switching between them without professional oversight can lead to lower effectiveness and adverse effects.

Wegovy vs. Other Weight Loss Injections

GLP-1 receptor agonists (Wegovy (semaglutide) and Saxenda (liraglutide)) are both used for weight management; they differ in efficacy, dosing, and convenience. The results of the clinical trial show that Wegovy leads to greater weight loss i.e.15%, compared to Saxenda, which results in 5-10% weight loss with once-daily injection. Wegovy is injected once weekly under the skin (subcutaneously) while Saxenda requires daily injection, which can be less convenient for long-term use.

Both medications are expensive, and their coverage varies across insurance providers and countries. For example, in the UK, Wegovy may be available on the NHS for weight management if certain criteria are met, while Saxenda is sometimes available privately or under limited NHS programs. Overall, Wegovy results are better and dosing is less frequent, making it a preferred option for many patients and clinicians.

Can I Get Treated with Wegovy on the NHS?

If you meet certain criteria, you may be able to get semaglutide (Wegovy) from the NHS. The criteria for eligibility entail that you have a Body Mass Index (BMI) of 35 kg/m² or higher, and have at least one weight-related condition, i.e., hypertension or cardiovascular disease. 

In some cases, individuals with a BMI between 30 and 34.9 kg/m² may be qualified if they fit other criteria for referral to specialist weight management services (Tier 3) and have significant health issues.

Access to Wegovy is limited due to the NHS rollout and the constraints of supply. Only specialist Tier 3 weight management services are available at the moment, which are accessible across all regions. Initiating Wegovy therapy requires these services, which offer multidisciplinary support like dietary and lifestyle interventions.

If a referral to a Tier 3 service is required to pursue this treatment, you will need to consult your GP. Be prepared for a potential waiting period due to the high demand and limited service availability.

Who Can Use Wegovy?

Wegovy is approved for people, ages 18 and older, who have a BMI of 30 or higher or a BMI of 27 or higher with certain weight-related health conditions. Semaglutide is not suitable for use by pregnant women or by people who are allergic to Semaglutide. Wegovy is not intended for cosmetic weight loss; it is designed for long-term use. In addition to this, eligibility criteria also include a commitment to lifestyle changes.

Wegovy Dosage

The dosage of Wegovy starts at 0.25 mg once weekly and is gradually increased to 2.4 mg once weekly over 16-20 weeks. This titration schedule reduces the risk of GI side effects such as nausea and helps your body adjust to the new medicine. For enhanced effectiveness and safety, adhere to your dosing plan, including: 

• Month 1: 0.25 mg once a week.
• Month 2: 0.5 mg once a week
• Month 3: 1 mg once a week
• Month 4: 1.7 mg once a week
• Month 5 & beyond: 2.4 mg once a week (maintenance dose)

Wegovy maintenance dose is 2.4 mg once weekly. If 2.4 mg is not tolerated, your doctor may lower the dose to 1.7 mg. If you are unable to tolerate 1.7 mg once weekly, discontinue Wegovy. 

What Type of Food You Should Not Eat While Taking Wegovy?

While on Wegovy, it is best to limit the amount of high-fat, greasy, or sugary food in your diet because this can worsen nausea and stomach discomfort. Eat a balanced and nutritious diet rich in vegetables, fruits, lean protein, and whole grains. Also, limit alcohol consumption and stay well hydrated for optimal results and to avoid side effects. 

Wegovy: Are There Any Side Effects or Long-Term Risks

The most common side effects of Wegovy include nausea, constipation, diarrhea, and headache, most often at the time of increasing the dose. Some more serious, though rare risks include pancreatitis, gallbladder problems, and kidney problems. Its long-term safety or associated risks have not been studied, so regular monitoring is recommended by a healthcare provider while receiving the treatment.

Let’s Wrap Up!

No doubt, Wegovy has shown promising results in long-term weight management for those with obesity or weight-related health problems. Although it is not a cosmetic solution or a quick fix, it can lead to optimal and sustained results when combined with medical support and healthy lifestyle changes. Just like any other medication, you need to know its eligibility criteria, potential side effects, and commitment. Before taking Wegovy injection, consult your doctor to evaluate whether this medicine is safe and appropriate for you.

How to minimize Wegovy side effects?

To minimize Wegovy side effects, start with a lower dose and gradually increase it, stay well-hydrated, eat smaller, low-fat meals, and avoid overeating. If symptoms persist or get worse, consult your doctor. 

What should you expect for the initial week of Wegovy?

During the first week of Wegovy, you will start with a low dose of 0.25 mg to let your body adjust. You may experience mild side effects such as fatigue or nausea, which may settle as your body adjusts to the new drug. Stay well-hydrated and eat balanced meals to manage discomfort. 

What happens if you miss a dose of Wegovy?

If you forget to take Wegovy and it is less than Less than 2 days (48 hours) away, do not take the dose. Instead, wait to take the next dose on the regularly scheduled day.. However, More than 2 days (48 hours) away, take the missed dose as soon as possible.

How quickly do Wegovy injections work?

Wegovy injections start to show weight loss results within the first few weeks; however, the noticeable results may take several months. For optimal results, stick to your dose and stay consistent with lifestyle changes. 

Where can I buy Wegovy online in the UK?

In the UK, you can buy Wegovy through licensed pharmacies, whether online or local. Avoid unregulated sources to avoid counterfeit Wegovy products, as they have been linked to serious health risks, including hospitalization.

How much weight will I lose in a month with Wegovy?

You can lose around 5-10% of your initial body weight in the first month with Wegovy. However, the results vary based on your activity, diet, dosage, and response.

Resources

STEP 1 clinical study

https://pmc.ncbi.nlm.nih.gov/articles/PMC8717485/

The results of the clinical trial show that Wegovy leads to greater weight loss i.e.15%